Aveanna Healthcare (AVAH) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jul 4, 2026
- EPS actual
- $0.22
- EPS estimate
- $0.17
- EPS surprise
- +30.72%
- Revenue surprise
- +4.99%
- Revenue
- $670.5M
- Revenue estimate
- $638.6M
- Reported
- Aug 13, 2026
Aveanna Healthcare reported Q2 2026 results on August 13, 2026. Earnings per share were $0.22, ahead of the $0.17 estimate by 30.72%. Revenue of $670.5 million topped the $638.6 million consensus by about 5%. Compared with Q2 2025, EPS rose about 22% from $0.18 and revenue rose about 14% from $589.6 million. Both are the highest in the table.
The 20 quarters shown trace a move from losses back to profit. Aveanna lost money in seven quarters between Q3 2022 and Q1 2024, and full-year 2023 was a loss of $0.12 per share. Every quarter since Q2 2024 has been profitable. Annual EPS went from $0.01 in 2022 to $0.05 in 2024 and $0.60 in 2025. The first half of 2026 adds up to $0.40, about 43% more than the $0.28 a year earlier. Quarterly revenue grew about 63% from $411.3 million in Q3 2021, the first quarter shown. Aveanna beat the EPS estimate in 13 of 20 quarters, and in each of the last 11.
Third-quarter results came out between November 6 and November 15 in each of the past five years. That points to early or mid-November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $0.17 | $0.22 | +30.72% | $670.5M | SEC |
| Q1 2026 | May 14, 2026 | $0.13 | $0.18 | +43.88% | $647.9M | SEC |
| Q4 2025 | Mar 19, 2026 | $0.15 | $0.17 | +12.96% | $662.5M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.10 | $0.15 | +47.49% | $621.9M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.04 | $0.18 | +402.79% | $589.6M | SEC |
| Q1 2025 | May 8, 2025 | −$0.00 | $0.10 | +3325.81% | $559.2M | SEC |
| Q4 2024 | Mar 13, 2025 | $0.00 | $0.05 | +9900.00% | $519.9M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.01 | $0.02 | +260.00% | $509.0M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.02 | $0.01 | +148.78% | $505.0M | SEC |
| Q1 2024 | May 9, 2024 | −$0.05 | −$0.03 | +39.88% | $490.7M | SEC |
| Q4 2023 | Mar 14, 2024 | −$0.02 | −$0.02 | +19.68% | $478.8M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.02 | −$0.03 | −37.61% | $478.0M | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.04 | −$0.02 | +45.21% | $471.9M | SEC |
| Q1 2023 | May 11, 2023 | −$0.06 | −$0.05 | +16.94% | $466.4M | SEC |
| Q4 2022 | Mar 16, 2023 | −$0.02 | −$0.03 | −40.85% | $451.1M | SEC |
| Q3 2022 | Nov 9, 2022 | $0.04 | −$0.03 | −181.52% | $443.0M | SEC |
| Q2 2022 | Aug 11, 2022 | $0.06 | $0.03 | −48.72% | $443.0M | SEC |
| Q1 2022 | May 11, 2022 | $0.06 | $0.04 | −33.44% | $450.5M | SEC |
| Q4 2021 | Mar 28, 2022 | $0.11 | $0.10 | −10.31% | $414.1M | SEC |
| Q3 2021 | Nov 15, 2021 | $0.12 | $0.11 | −6.78% | $411.3M | SEC |
Quarterly revenue
Frequently asked questions
When did Aveanna Healthcare (AVAH) last report earnings?
Aveanna Healthcare last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did AVAH beat earnings estimates?
Yes. Aveanna Healthcare reported EPS of $0.22 for Q2 2026 against a $0.17 estimate — a 30.72% beat.
How much revenue did AVAH report last quarter?
Aveanna Healthcare reported $670.5M in revenue for Q2 2026, against a consensus estimate of $638.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.